Heart 2007;93:149-151
EDITORIAL
The effect of intensive lipid lowering on coronary atheroma and clinical outcome
Department of Cardiology, Royal Infirmary of Edinburgh, Edinburgh, UK
Correspondence to:
Dr Neal Uren
Department of Cardiology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK; nealuren{at}hotmail.com
The association between raised plasma cholesterol and cardiovascular risk is well established, with consistent evidence associating LDL-cholesterol reduction with a reduction in primary and secondary cardiovascular events. It is believed that intensive lipid lowering may improve clinical outcomes further by acting to stabilise plaque and preventing plaque progression, ultimately reducing plaque vulnerability. However, it remains uncertain whether a continued clinical benefit occurs with intensive lipid lowering or if there is a threshold level below which no further benefit occurs.
Abbreviations: CRP, C-reactive protein; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; IL-6, interleukin-6; M-CSF, macrophage-colony stimulating factor; MI, myocardial infarction; PPAR, peroxisome proliferator-activated receptor
Keywords: atherosclerosis; cholesterol; hydroxymethylglutaryl-CoA reductase inhibitors; inflammation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
